{"id":847170,"date":"2025-05-06T08:05:38","date_gmt":"2025-05-06T12:05:38","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-may-investor-events\/"},"modified":"2025-05-06T08:05:38","modified_gmt":"2025-05-06T12:05:38","slug":"compass-therapeutics-to-participate-in-upcoming-may-investor-events","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-may-investor-events\/","title":{"rendered":"Compass Therapeutics to Participate in Upcoming May Investor Events"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">BOSTON, May  06, 2025  (GLOBE NEWSWIRE) &#8212; Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics, today announced that the Company will participate in the following investor events during the month of May.<\/p>\n<p>\n        <strong>Details are as follows: <\/strong>\n      <\/p>\n<p>\n        <strong>The Citizens Life Sciences Conference<\/strong><br \/>\n        <br \/>\n        <strong>Location:<\/strong> New York, NY<br \/><strong>Date:<\/strong> Thursday, May 8, 2025 <br \/><strong>Time:<\/strong> 1:30 PM ET<br \/><strong>Webcast Link:<\/strong><strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fnnCQ0uNLHdfE9sUmI4Zjn0fqcFGLSJIri9qwjiatVzznASz48pROA3oGuVoWxG577bnxstFeSY4A0MGbCeYRLPFjk0LibUFvch66TCP9sY1BJVBR2ljFR_Vt1SqUKl5for5sg7d3Cj9Sqoz9DyBJQ==\" rel=\"nofollow\" target=\"_blank\">https:\/\/wsw.com\/webcast\/jmp65\/cmpx\/1692592<\/a><\/strong><\/p>\n<p>\n        <strong>H.C. Wainwright 3<\/strong><br \/>\n        <sup><br \/>\n          <strong>rd<\/strong><br \/>\n        <\/sup><br \/>\n        <strong> Annual BioConnect Investor Conference at NASDAQ<\/strong><br \/>\n        <br \/>\n        <strong>Location:<\/strong> New York, NY<br \/><strong>Date:<\/strong> Tuesday, May 20, 2025 <br \/><strong>Time:<\/strong> 11:30AM ET<br \/><strong>Webcast Link:<\/strong><strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fnnCQ0uNLHdfE9sUmI4ZjvWbj247uFhIfT6EdqxfVsMyVlJOau2vA6R0KZ8QCJY_YTFESS4shDWn-J8KH3uUz_-LPzLY16dPt2BqHsRxuMim8k0h28wfhgOmzdtibp0othgowFfVc1dNvz_GdOYfV6dEbDmmQYzlBufLQWeeiNQWiOxxR0P-detJhK2AeJ1BhDEGB6LtCPRg_IAqjsGMGklWyLa4iEcI7XhlC5WGkjY=\" rel=\"nofollow\" target=\"_blank\">https:\/\/journey.ct.events\/view\/29729b86-5109-46dc-a93b-1cf3560aa9a1<\/a><\/strong><\/p>\n<p>\n        <strong>Virtual\/Replay availability:\u00a0<\/strong>Presentations will be archived for 90 days on Compass\u2019\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0XKy9gPWCVhgU0Co9LDmGoQei6Y79CIhPoX7SIR-O8CI-0HRKKK1ICEhr6KqhZhUvwhT9G1Hd9k457z-RULrCc2GVGUhUkoNBMnzg3P2F_Jj6FBuymJhsGvszArTqeZ2\" rel=\"nofollow\" target=\"_blank\"><strong>Events<\/strong><\/a>\u00a0page.<\/p>\n<p>\n        <strong>About Compass Therapeutics<\/strong><br \/>\n        <br \/>Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. Compass\u2019s scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. The company pipeline of novel product candidates is designed to target multiple critical biological pathways required for an effective anti-tumor response. These include modulation of the microvasculature via angiogenesis-targeted agents, induction of a potent immune response via activators on effector cells in the tumor microenvironment, and alleviation of immunosuppressive mechanisms used by tumors to evade immune surveillance. Compass plans to advance its product candidates through clinical development as both standalone therapies and in combination with proprietary pipeline antibodies based on supportive clinical and nonclinical data. The company was founded in 2014 and is headquartered in Boston, Massachusetts. For more information, visit the Compass Therapeutics website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fnnCQ0uNLHdfE9sUmI4ZjkC9l5WuE00UGIdUKRmDljccD7Sr6jIqL1Cg4WwfWEV4NVokmRx3ts-K8ZTeDIocgUYyewn142fmBQJvnt9PJxky6RS3rfMn_uJIFI5u2qHhi1GusrVHvG64tBms0Ros_Q==\" rel=\"nofollow\" target=\"_blank\">https:\/\/www.compasstherapeutics.com<\/a>.<\/p>\n<p>\n        <strong>Investor Contact<\/strong><br \/>\n        <br \/>\n        <strong><br \/>\n          <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pRiN_ZXLi7Sej-Gp_0R_vYRppVbtvM1n8egyBl-UJF0WuSl1LyQyCvHLc2WrOeCpw0FfLJgCx61yIzyIPF8nTV01zbsiL_RwUB6bLaFCw5E0Ne_xpFYolzfrxN6EyI3M\" rel=\"nofollow\" target=\"_blank\">ir@compasstherapeutics.com<\/a><br \/>\n        <\/strong>\n      <\/p>\n<p>\n        <strong>Media Contact<\/strong><br \/>\n        <br \/>Anna Gifford, Chief of Staff<br \/><strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=HQi06jLRni35_8zcl2VCiV5Xu6Xv40M15cQ-g_fc9X-8N2CjfDJtB2v3dPXnLlaLSM9krM-9XzswsExPcMZkcYSiTAm84VO1gRi_si48TjepAlInJRgKGRYl_Gw8fJ2U\" rel=\"nofollow\" target=\"_blank\">media@compasstherapeutics.com<\/a><\/strong><br \/>617-500-8099<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ0NDg2MSM2OTIyMzM5IzIyMDI0MjI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MzMzZjliODUtZmI2NC00MjQwLTk4MjEtZDQzN2JkNDQ2NmY0LTEyMTM5NzUtMjAyNS0wNS0wNi1lbg==\/tiny\/Compass-Therapeutics.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BOSTON, May 06, 2025 (GLOBE NEWSWIRE) &#8212; Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics, today announced that the Company will participate in the following investor events during the month of May. Details are as follows: The Citizens Life Sciences Conference Location: New York, NYDate: Thursday, May 8, 2025 Time: 1:30 PM ETWebcast Link:https:\/\/wsw.com\/webcast\/jmp65\/cmpx\/1692592 H.C. Wainwright 3 rd Annual BioConnect Investor Conference at NASDAQ Location: New York, NYDate: Tuesday, May 20, 2025 Time: 11:30AM ETWebcast Link:https:\/\/journey.ct.events\/view\/29729b86-5109-46dc-a93b-1cf3560aa9a1 Virtual\/Replay availability:\u00a0Presentations will be archived for 90 days on Compass\u2019\u00a0Events\u00a0page. About Compass Therapeutics Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. Compass\u2019s scientific focus is on the relationship &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-may-investor-events\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Compass Therapeutics to Participate in Upcoming May Investor Events&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-847170","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Compass Therapeutics to Participate in Upcoming May Investor Events - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-may-investor-events\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Compass Therapeutics to Participate in Upcoming May Investor Events - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BOSTON, May 06, 2025 (GLOBE NEWSWIRE) &#8212; Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics, today announced that the Company will participate in the following investor events during the month of May. Details are as follows: The Citizens Life Sciences Conference Location: New York, NYDate: Thursday, May 8, 2025 Time: 1:30 PM ETWebcast Link:https:\/\/wsw.com\/webcast\/jmp65\/cmpx\/1692592 H.C. Wainwright 3 rd Annual BioConnect Investor Conference at NASDAQ Location: New York, NYDate: Tuesday, May 20, 2025 Time: 11:30AM ETWebcast Link:https:\/\/journey.ct.events\/view\/29729b86-5109-46dc-a93b-1cf3560aa9a1 Virtual\/Replay availability:\u00a0Presentations will be archived for 90 days on Compass\u2019\u00a0Events\u00a0page. About Compass Therapeutics Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. Compass\u2019s scientific focus is on the relationship &hellip; Continue reading &quot;Compass Therapeutics to Participate in Upcoming May Investor Events&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-may-investor-events\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-06T12:05:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ0NDg2MSM2OTIyMzM5IzIyMDI0MjI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-may-investor-events\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-may-investor-events\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Compass Therapeutics to Participate in Upcoming May Investor Events\",\"datePublished\":\"2025-05-06T12:05:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-may-investor-events\\\/\"},\"wordCount\":283,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-may-investor-events\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ0NDg2MSM2OTIyMzM5IzIyMDI0MjI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-may-investor-events\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-may-investor-events\\\/\",\"name\":\"Compass Therapeutics to Participate in Upcoming May Investor Events - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-may-investor-events\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-may-investor-events\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ0NDg2MSM2OTIyMzM5IzIyMDI0MjI=\",\"datePublished\":\"2025-05-06T12:05:38+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-may-investor-events\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-may-investor-events\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-may-investor-events\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ0NDg2MSM2OTIyMzM5IzIyMDI0MjI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ0NDg2MSM2OTIyMzM5IzIyMDI0MjI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-may-investor-events\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Compass Therapeutics to Participate in Upcoming May Investor Events\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Compass Therapeutics to Participate in Upcoming May Investor Events - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-may-investor-events\/","og_locale":"en_US","og_type":"article","og_title":"Compass Therapeutics to Participate in Upcoming May Investor Events - Market Newsdesk","og_description":"BOSTON, May 06, 2025 (GLOBE NEWSWIRE) &#8212; Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics, today announced that the Company will participate in the following investor events during the month of May. Details are as follows: The Citizens Life Sciences Conference Location: New York, NYDate: Thursday, May 8, 2025 Time: 1:30 PM ETWebcast Link:https:\/\/wsw.com\/webcast\/jmp65\/cmpx\/1692592 H.C. Wainwright 3 rd Annual BioConnect Investor Conference at NASDAQ Location: New York, NYDate: Tuesday, May 20, 2025 Time: 11:30AM ETWebcast Link:https:\/\/journey.ct.events\/view\/29729b86-5109-46dc-a93b-1cf3560aa9a1 Virtual\/Replay availability:\u00a0Presentations will be archived for 90 days on Compass\u2019\u00a0Events\u00a0page. About Compass Therapeutics Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. Compass\u2019s scientific focus is on the relationship &hellip; Continue reading \"Compass Therapeutics to Participate in Upcoming May Investor Events\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-may-investor-events\/","og_site_name":"Market Newsdesk","article_published_time":"2025-05-06T12:05:38+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ0NDg2MSM2OTIyMzM5IzIyMDI0MjI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-may-investor-events\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-may-investor-events\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Compass Therapeutics to Participate in Upcoming May Investor Events","datePublished":"2025-05-06T12:05:38+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-may-investor-events\/"},"wordCount":283,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-may-investor-events\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ0NDg2MSM2OTIyMzM5IzIyMDI0MjI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-may-investor-events\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-may-investor-events\/","name":"Compass Therapeutics to Participate in Upcoming May Investor Events - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-may-investor-events\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-may-investor-events\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ0NDg2MSM2OTIyMzM5IzIyMDI0MjI=","datePublished":"2025-05-06T12:05:38+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-may-investor-events\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-may-investor-events\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-may-investor-events\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ0NDg2MSM2OTIyMzM5IzIyMDI0MjI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ0NDg2MSM2OTIyMzM5IzIyMDI0MjI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-may-investor-events\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Compass Therapeutics to Participate in Upcoming May Investor Events"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/847170","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=847170"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/847170\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=847170"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=847170"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=847170"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}